Publications
-
Brown, Elizabeth J., Balaguer-Lluna, Leire, Cribbs, Adam P., Philpott, Martin, Campo, Leticia, Browne, Molly, Wong, Jong Fu, Oppermann, Udo, Carcaboso AM, Bullock, Alex N. and Farnie, Gillian.
PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo
SCIENTIFIC REPORTS . 14(1): .
-
Wiese M, Pohlmeier B, Kubiak K, El-Khouly FE, Sitte M, Carcaboso AM, Baugh JN, Perwein T, Nussbaumer G, Karremann M, Gielen GH, Salinas G and Kramm CM.
Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential
Journal of Traditional and Complementary Medicine . 14(1): 101-108.
-
Aschero MR, Ganiewich D, Lamas G, Restrepo-Perdomo CA, Ottaviani D, Zugbi S, Camarero S, Néspoli E, Cuadrado-Vilanova M, Pérez-Jaume S, Pascual-Pastó G, Sampor C, Grigorovski N, Salas B, Suñol M, Carcaboso AM, Mora J, de Dávila MTG, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lubieniecki F and Chantada G.
Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma
PEDIATRIC BLOOD & CANCER . 71(1): .
-
Zugbi S, Aschero MR, Ganiewich D, Cancela MB, Winter U, Ottaviani D, Sampor C, Dinardi M, Torbidoni AV, Mena M, Balaguer-Lluna L, Lamas G, Sgroi M, Lagomarsino E, Lubieniecki F, Fandiño A, Radvanyi F, Abramson DH, Podhajcer O, Llera AS, Cafferata EG, Chantada G, Carcaboso AM and Schaiquevich P.
Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 64(15): 27-27.
-
Lee K, Yun S, Park J, Lee S, Carcaboso AM, Yi SJ and Kim K.
Dimethyl alpha-ketoglutarate inhibits proliferation in diffuse intrinsic pontine glioma by reprogramming epigenetic and transcriptional networks
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS . 677: 6-12.
-
Fanlo, L, Gomez-Gonzalez S, Rozalen, C, Perez-Nunez, I, Sangrador, I, Tomas-Daza, L, Gautier, EL, Usieto, S, Rebollo, E, Vilà-Ubach M, Carcaboso AM, Javierre, BM, Celia-Terrassa, T, Lavarino C, Marti, E and Le Dreau, G.
Neural crest-related NXPH1/a-NRXN signaling opposes neuroblastoma malignancy by inhibiting organotropic metastasis
Oncogene . 42(28): 2218-2233.
-
Mensali, N, Köksal, H, Joaquina, S, Wernhoff, P, Casey, NP, Romecin, P, Panisello, C, Rodriguez, R, Vimeux, L, Juzeniene, A, Myhre, MR, Fåne, A, Ramírez, CC, Maggadottir, SM, Duru, AD, Georgoudaki, AM, Grad, I, Maturana, AD, Gaudernack, G, Kvalheim, G, Carcaboso AM, de Alava, E, Donnadieu, E, Bruland, OS, Menendez, P, Inderberg, EM and Wälchli, S.
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
NATURE COMMUNICATIONS . 14(1): . Number of citations: 4
-
Aschero MR, Castillo H, Baulenas-Farrés M, Resa-Parés C, Jiménez-Cabaco A, Rodriguez E, Monterrubio C, Pérez-Jaume S, Suñol M, Chantada G, Lavarino C, Mora J and Carcaboso AM.
Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma
PEDIATRIC BLOOD & CANCER . 70(6): . Number of citations: 2
-
Thirant, C, Peltier, A, Durand, S, Kramdi, A, Louis-Brennetot, C, Pierre-Eugene, C, Gautier, M, Costa, A, Grelier, A, Zaïdi S, Gruel, N, Jimenez, I, Lapouble, E, Pierron, G, Sitbon, D, Brisse, HJ, Gauthier, A, Freneaux, P, Grossetête S, Baudrin, LG, Raynal, V, Baulande, S, Bellini, A, Bhalshankar, J, Carcaboso AM, Geoerger, B, Rohrer, H, Surdez, D, Boeva, V, Schleiermacher, G, Delattre, O and Janoueix-Lerosey, I.
Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma
NATURE COMMUNICATIONS . 14(1): 2575-2575. Number of citations: 6
-
Tucker ER, Jiménez I, Chen L, Bellini A, Gorrini C, Calton E, Gao Q, Che H, Poon E, Jamin Y, Martins Da Costa B, Barker K, Shrestha S, Hutchinson JC, Dhariwal S, Goodman A, Del Nery E, Gestraud P, Bhalshankar J, Iddir Y, Saberi-Ansari E, Saint-Charles A, Geoerger B, Marques Da Costa ME, Pierre-Eugene C, Janoueix-Lerosey I, Decaudin D, Némati F, Carcaboso AM, Surdez D, Delattre O, George SL, Chesler L, Tweddle DA and Schleiermacher G.
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
CLINICAL CANCER RESEARCH . 29(7): 1317-1331. Number of citations: 6